Camurus AB, a Swedish biopharmaceutical company, reported its first-quarter financial results, showing a 5% year-over-year decrease in revenue to 533 million Swedish kronor. Product sales declined by 12% to 426 million kronor, while royalty income surged by 44% to 106 million kronor. The company's operating profit saw a 30% drop to 168 million kronor. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON This is a financial earnings report for a biopharmaceutical company, not directly related to AI.